A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Depoxythilone (UTD1) in Patients with Advanced Solid Tumors.

Trial Profile

A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Depoxythilone (UTD1) in Patients with Advanced Solid Tumors.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Depoxythilone (Primary) ; Antineoplastics
  • Indications Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 31 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top